Principal Financial Group
PACB icon

Principal Financial Group’s Pacific Biosciences PACB Stock Holding History

Principal Financial Group’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.6K Buy
20,581
+8,583
+72% +$12.5K ﹤0.01% 2138
2026
Q1 		$15.8K Sell
11,998
-117
-1% -$209 ﹤0.01% 2170
2025
Q4 		$22.7K Sell
12,115
-7,494
-38% -$14.4K ﹤0.01% 2173
2025
Q3 		$25.1K Buy
19,609
+1,007
+5% +$1.36K ﹤0.01% 2236
2025
Q2 		$23.1K Buy
18,602
+167
+0.9% +$193 ﹤0.01% 2214
2025
Q1 		$21.8K Buy
18,435
+3,187
+21% +$4.89K ﹤0.01% 2145
2024
Q4 		$27.9K Sell
15,248
-3,917
-20% -$7.65K ﹤0.01% 2187
2024
Q3 		$32.6K Sell
19,165
-17,601
-48% -$28.9K ﹤0.01% 2195
2024
Q2 		$50.4K Sell
36,766
-23,612
-39% -$47.7K ﹤0.01% 2282
2024
Q1 		$226K Sell
60,378
-1,095
-2% -$6.41K ﹤0.01% 2147
2023
Q4 		$603K Sell
61,473
-2,751
-4% -$22.5K ﹤0.01% 1921
2023
Q3 		$536K Buy
64,224
+4,488
+8% +$51.3K ﹤0.01% 1933
2023
Q2 		$794K Sell
59,736
-955
-2% -$11.6K ﹤0.01% 1874
2023
Q1 		$703K Buy
60,691
+12,007
+25% +$119K ﹤0.01% 1907
2022
Q4 		$398K Sell
48,684
-244
-0.5% -$2.1K ﹤0.01% 2027
2022
Q3 		$284K Buy
48,928
+12,293
+34% +$70.5K ﹤0.01% 2098
2022
Q2 		$162K Sell
36,635
-10,744
-23% -$65.3K ﹤0.01% 2331
2022
Q1 		$431K Sell
47,379
-857
-2% -$9.87K ﹤0.01% 2153
2021
Q4 		$986K Sell
48,236
-18,355
-28% -$443K ﹤0.01% 1983
2021
Q3 		$1.7M Sell
66,591
-5,058
-7% -$150K ﹤0.01% 1900
2021
Q2 		$2.5M Sell
71,649
-4,567
-6% -$133K ﹤0.01% 1859
2021
Q1 		$2.54M Sell
76,216
-897
-1% -$31.4K ﹤0.01% 1816
2020
Q4 		$2M Buy
77,113
+21,173
+38% +$360K ﹤0.01% 1799
2020
Q3 		$552K Buy
55,940
+152
+0.3% +$875 ﹤0.01% 2002
2020
Q2 		$193K Buy
55,788
+35,786
+179% +$122K ﹤0.01% 2193
2020
Q1 		$61K Buy
20,002
+898
+5% +$3.68K ﹤0.01% 2146
2019
Q4 		$98K Sell
19,104
-3,246
-15% -$16.5K ﹤0.01% 2192
2019
Q3 		$115K Buy
22,350
+4,239
+23% +$23.7K ﹤0.01% 2175
2019
Q2 		$110K Sell
18,111
-1,048
-5% -$7.35K ﹤0.01% 2177
2019
Q1 		$139K Sell
19,159
-16,733
-47% -$121K ﹤0.01% 2145
2018
Q4 		$265K Sell
35,892
-8,571
-19% -$54.3K ﹤0.01% 2058
2018
Q3 		$240K Buy
44,463
+5,632
+15% +$24.2K ﹤0.01% 2129
2018
Q2 		$138K Buy
38,831
+3,353
+9% +$9.3K ﹤0.01% 2201
2018
Q1 		$72K Sell
35,478
-644
-2% -$1.67K ﹤0.01% 2167
2017
Q4 		$95K Buy
36,122
+22,295
+161% +$78.1K ﹤0.01% 2190
2017
Q3 		$73K Buy
+13,827
New +$59.4K ﹤0.01% 2152
2017
Q2 		– Sell
-15,074
Closed -$78K – 2279
2017
Q1 		$78K Sell
15,074
-479
-3% -$2.35K ﹤0.01% 2158
2016
Q4 		$59K Sell
15,553
-9,811
-39% -$71.3K ﹤0.01% 2192
2016
Q3 		$227K Buy
25,364
+10,942
+76% +$91.5K ﹤0.01% 2018
2016
Q2 		$101K Buy
14,422
+2,227
+18% +$20.3K ﹤0.01% 2086
2016
Q1 		$104K Buy
12,195
+1,948
+19% +$19.2K ﹤0.01% 2084
2015
Q4 		$135K Hold
10,247
– – ﹤0.01% 2090
2015
Q3 		$38K Sell
10,247
-6,528
-39% -$31.9K ﹤0.01% 2154
2015
Q2 		$97K Sell
16,775
-251
-1% -$1.45K ﹤0.01% 2135
2015
Q1 		$100K Buy
17,026
+1,042
+7% +$7.18K ﹤0.01% 2102
2014
Q4 		$125K Sell
15,984
-2,808
-15% -$18K ﹤0.01% 2093
2014
Q3 		$92K Hold
18,792
– – ﹤0.01% 2150
2014
Q2 		$116K Sell
18,792
-1,484
-7% -$7.43K ﹤0.01% 2189
2014
Q1 		$108K Sell
20,276
-415
-2% -$2.62K ﹤0.01% 2224
2013
Q4 		$108K Buy
+20,691
New +$95K ﹤0.01% 2239
2013
Q3 		– Sell
-20,519
Closed -$52K – 2289
2013
Q2 		$52K Buy
+20,519
New +$51.1K ﹤0.01% 2239

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Principal Financial Group's PACB Position: Q2 2026 in Review

Principal Financial Group increased its Pacific Biosciences (PACB) stake by 72% in Q2 2026, buying an estimated $12.5K and bringing the position to 20,581 shares worth $34.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2138.

Principal Financial Group first reported a position in PACB in Q2 2013 and has held it in 51 quarters since. The position peaked at $2.54M in Q1 2021. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • Principal Financial Group held 20,581 shares of Pacific Biosciences worth $34.6K as of Q2 2026.
  • Principal Financial Group bought 8,583 Pacific Biosciences shares in Q2 2026, an estimated $12.5K.
  • Pacific Biosciences made up ﹤0.01% of Principal Financial Group's portfolio in Q2 2026, its #2138 holding.
  • Principal Financial Group first reported a position in Pacific Biosciences in Q2 2013 and has held it in 51 quarters since.
  • Principal Financial Group's Pacific Biosciences position peaked at $2.54M in Q1 2021.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.